Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

2.

Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.

Fitton A, Goa KL.

Drugs. 1995 Oct;50(4):691-713. Review.

PMID:
8536554
3.

The clinical efficacy of lamotrigine as an antiepileptic drug.

Pellock JM.

Neurology. 1994 Nov;44(11 Suppl 8):S29-35. Review.

PMID:
7970004
4.

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.

Goa KL, Ross SR, Chrisp P.

Drugs. 1993 Jul;46(1):152-76. Review.

PMID:
7691504
5.

Lamotrigine versus carbamazepine monotherapy for epilepsy.

Gamble CL, Williamson PR, Marson AG.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001031. Review. Update in: Cochrane Database Syst Rev. 2016 Nov 14;11:CD001031.

PMID:
16437428
6.

Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.

Alvarez N, Besag F, Iivanainen M.

J Intellect Disabil Res. 1998 Dec;42 Suppl 1:1-15. Review.

PMID:
10030426
7.

Rational polytherapy.

French JA, Faught E.

Epilepsia. 2009 Sep;50 Suppl 8:63-8. doi: 10.1111/j.1528-1167.2009.02238.x. Review.

8.

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.

Posner EB, Mohamed K, Marson AG.

Cochrane Database Syst Rev. 2003;(3):CD003032. Review. Update in: Cochrane Database Syst Rev. 2005;(4):CD003032.

PMID:
12917940
9.

A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy.

Gamble C, Williamson PR, Chadwick DW, Marson AG.

Neurology. 2006 May 9;66(9):1310-7. Review.

PMID:
16682660
10.

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T.

Epilepsia. 2006 Jul;47(7):1094-120. Review.

11.

Lamotrigine. A review of its use in childhood epilepsy.

Culy CR, Goa KL.

Paediatr Drugs. 2000 Jul-Aug;2(4):299-330. Review.

PMID:
10946418
12.

[Lamotrigine monotherapy in children with epilepsy: a systematic review].

Liu YT, Zhang LL, Huang L, Zeng LN.

Zhongguo Dang Dai Er Ke Za Zhi. 2016 Jul;18(7):582-8. Review. Chinese.

PMID:
27412538
13.

Lamotrigine--a clinical overview.

Wallace SJ.

Seizure. 1994 Dec;3 Suppl A:47-51. Review.

PMID:
7894852
14.

Safety review of adult clinical trial experience with lamotrigine.

Messenheimer J, Mullens EL, Giorgi L, Young F.

Drug Saf. 1998 Apr;18(4):281-96. Review.

PMID:
9565739
15.

Epilepsy treatment in adults and adolescents: Expert opinion, 2016.

Shih JJ, Whitlock JB, Chimato N, Vargas E, Karceski SC, Frank RD.

Epilepsy Behav. 2017 Apr;69:186-222. doi: 10.1016/j.yebeh.2016.11.018. Epub 2017 Feb 23. Review.

PMID:
28237319
16.

Lamotrigine XR conversion to monotherapy: first study using a historical control group.

French JA, Temkin NR, Shneker BF, Hammer AE, Caldwell PT, Messenheimer JA.

Neurotherapeutics. 2012 Jan;9(1):176-84. doi: 10.1007/s13311-011-0088-3. Review.

17.

[Therapy of epilepsy: current strategy and tactics].

Karlov VA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2004;104(8):28-34. Review. Russian.

PMID:
15554139
18.

[Rational combinations of antiepileptic drugs for refractory epilepsy].

Yoshino A.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Apr;31(2):65-72. Review. Japanese.

PMID:
21626890
19.

Pharmacotherapy of focal epilepsy.

Iyer A, Marson A.

Expert Opin Pharmacother. 2014 Aug;15(11):1543-51. doi: 10.1517/14656566.2014.922544. Epub 2014 May 26. Review.

PMID:
24856909
20.

The tolerability of lamotrigine in children.

Messenheimer JA, Giorgi L, Risner ME.

Drug Saf. 2000 Apr;22(4):303-12. Review.

PMID:
10789824

Supplemental Content

Support Center